| SEC Info | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing As/For/On Docs:Pgs Issuer Agent 6/12/07 Comscore/Inc S-1/A 10:396 Bowne of Dc 01/FA
Document/Exhibit Description Pages Size
1: S-1/A Pre-Effective Amendment to Registration Statement HTML 1,617K
(General Form)
2: EX-3.1 Articles of Incorporation/Organization or By-Laws HTML 123K
3: EX-3.3 Articles of Incorporation/Organization or By-Laws HTML 22K
4: EX-3.4 Articles of Incorporation/Organization or By-Laws HTML 127K
5: EX-4.1 Instrument Defining the Rights of Security Holders HTML 8K
6: EX-10.19 Material Contract HTML 10K
7: EX-10.20 Material Contract HTML 51K
8: EX-10.21 Material Contract HTML 10K
9: EX-10.22 Material Contract HTML 403K
10: EX-23.1 Consent of Experts or Counsel HTML 6K
| sv1za |
| Delaware | 7389 | 54-19555550 | ||
|
(State or other jurisdiction
of incorporation or organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification Number) |
|
Jeffrey D. Saper, Esq. Robert G. Day, Esq. Wilson Sonsini Goodrich & Rosati, Professional Corporation 650 Page Mill Road Palo Alto, California 94304 |
Christiana L. Lin, Esq. General Counsel comScore, Inc. 11465 Sunset Hills Road, Suite 200 Reston, Virginia 20190 Telephone: (703) 438-2000 Facsimile: (703) 438-2051 |
Andrew J. Pitts, Esq. Cravath, Swaine & Moore LLP Worldwide Plaza 825 Eighth Avenue New York, New York 10019 Telephone: (212) 474-1000 Facsimile: (212) 474-3700 |
||
|
Mark R. Fitzgerald, Esq. Wilson Sonsini Goodrich & Rosati, Professional Corporation 1700 K Street, N.W., Fifth Floor Washington, D.C. 20006 Telephone: (202) 973-8800 Facsimile: (202) 973-8899 |
|
Proposed Maximum |
Proposed Maximum |
Amount of |
||||||||||
|
Title of each Class of |
Amount to be |
Offering Price per |
Aggregate Offering |
Registration |
||||||||
| Securities to be Registered | Registered(1) | Share(2) | Price(2) | Fee(3) | ||||||||
|
Common Stock, par value $0.001 per
share
|
5,750,000 | $16.00 | $92,000,000 | $2,825 | ||||||||
| (1) | Includes 750,000 shares the underwriters have an option to purchase to cover over-allotments, if any. |
| (2) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457 under the Securities Act of 1933, as amended. |
| (3) | $2,648 previously paid by the Registrant. |
|
The
information in this prospectus is not complete and may be
changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is
effective. This prospectus is not an offer to sell these
securities and it is not soliciting an offer to buy these
securities in any jurisdiction where the offer or sale is not
permitted. |
|
Underwriting |
||||||
|
Price to |
Discounts and |
Proceeds to |
||||
| Public | Commissions | comScore | ||||
|
Per Share
|
$ | $ | $ | |||
|
Total
|
$ | $ | $ |
| Credit Suisse | Deutsche Bank Securities |
| William Blair & Company |
| Friedman Billings Ramsey |
| Jefferies & Company |
| Page | ||||
| 1 | ||||
| 9 | ||||
| 28 | ||||
| 29 | ||||
| 29 | ||||
| 30 | ||||
| 32 | ||||
| 34 | ||||
| 39 | ||||
| 62 | ||||
| 81 | ||||
| 86 | ||||
| 92 | ||||
| 101 | ||||
| 103 | ||||
| 107 | ||||
| 113 | ||||
| 115 | ||||
| 118 | ||||
| 122 | ||||
| 123 | ||||
| 123 | ||||
| 124 | ||||
| F-1 | ||||
1
| • | deepen relationships with current customers; | |
| • | grow our customer base; | |
| • | expand our digital marketing intelligence platform; |
2
| • | address emerging digital media; | |
| • | extend technology leadership; | |
| • | build brand awareness through media exposure; and | |
| • | grow internationally. |
3
| Common stock offered by us | 5,000,000 shares |
|
Common stock outstanding after this offering
|
27,385,274 shares |
| Use of proceeds | We intend to use the net proceeds from this offering for working capital, for capital expenditures and for other general corporate purposes. We may also use a portion of our net proceeds to fund potential acquisitions. We will not receive any proceeds from the sale of shares of our common stock by the selling stockholders, including for sales of their shares in the event that the underwriters exercise their option to purchase an additional 750,000 shares of our common stock from us and the selling stockholders. See “Use of Proceeds.” |
|
Proposed NASDAQ Global Market symbol
|
SCOR | |
| Risk factors | See “Risk Factors” and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in shares of our common stock. |
| • | 2,497,424 shares of common stock issuable upon exercise of options outstanding at a weighted-average exercise price of $2.07 per share; |
| • | 52,850 shares of our common stock issuable upon the settlement of outstanding restricted stock unit awards; |
| • | 456,754 shares of common stock reserved for future issuance under our 1999 Stock Plan; |
| • | 1,400,000 shares of common stock reserved for future issuance under our 2007 Equity Incentive Plan, which will be effective upon completion of this offering; and |
| • | 175,186 shares of common stock issuable upon the exercise of warrants, which total includes warrants for our preferred stock that will become exercisable for common stock after this offering, at a weighted-average exercise price of $4.87 per share. |
| • | a 1-for-5 reverse split of our common stock that will occur prior to the consummation of this offering; |
| • | the conversion, in accordance with our certificate of incorporation, of all our shares of outstanding preferred stock into an aggregate of 17,257,362 shares of our common stock; |
| • | no exercise by the underwriters of their option to purchase up to 750,000 additional shares to cover over-allotments, consisting of 63,030 shares to be issued directly by us and 686,970 shares to be purchased from the selling stockholders; and |
| • | the adoption of our amended and restated certificate of incorporation and bylaws that will occur immediately prior to the consummation of this offering. |
4
|
Three Months Ended |
||||||||||||||||||||
| Year Ended December 31, | March 31, | |||||||||||||||||||
| 2004 | 2005 | 2006 | 2006 | 2007 | ||||||||||||||||
| (Unaudited) | ||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||
|
Consolidated Statement of
Operations Data:
|
||||||||||||||||||||
|
Revenues
|
$ | 34,894 | $ | 50,267 | $ | 66,293 | $ | 14,985 | $ | 18,681 | ||||||||||
|
Cost of revenues(1)
|
13,153 | 18,218 | 20,560 | 5,148 | 5,388 | |||||||||||||||
|
Selling and marketing(1)
|
13,890 | 18,953 | 21,473 | 5,345 | 6,451 | |||||||||||||||
|
Research and development(1)
|
5,493 | 7,416 | 9,009 | 2,137 | 2,556 | |||||||||||||||
|
General and administrative(1)
|
4,982 | 7,089 | 8,293 | 1,918 | 2,507 | |||||||||||||||
|
Amortization
|
356 | 2,437 | 1,371 | 371 | 293 | |||||||||||||||
|
Total expenses from operations
|
37,874 | 54,113 | 60,706 | 14,919 | 17,195 | |||||||||||||||
|
(Loss) income from operations
|
(2,980 | ) | (3,846 | ) | 5,587 | 66 | 1,486 | |||||||||||||
|
Interest (expense) income, net
|
(246 | ) | (208 | ) | 231 | 11 | 97 | |||||||||||||
|
(Loss) gain from foreign currency
|
— | (96 | ) | 125 | 6 | (8 | ) | |||||||||||||
|
Revaluation of preferred stock
warrant liabilities
|
— | (14 | ) | (224 | ) | 2 | 11 | |||||||||||||
|
(Loss) income before income taxes
and cumulative effect of change in accounting principle
|
(3,226 | ) | (4,164 | ) | 5,719 | 85 | 1,586 | |||||||||||||
|
(Benefit) provision for income taxes
|
— | (182 | ) | 50 | — | 46 | ||||||||||||||
|
Net (loss) income before cumulative
effect of change in accounting principle
|
(3,226 | ) | (3,982 | ) | 5,669 | 85 | 1,540 | |||||||||||||
|
Cumulative effect of change in
accounting principle
|
— | (440 | ) | — | — | — | ||||||||||||||
|
Net (loss) income
|
(3,226 | ) | (4,422 | ) | 5,669 | 85 | 1,540 | |||||||||||||
|
Accretion of redeemable preferred
stock
|
(2,141 | ) | (2,638 | ) | (3,179 | ) | (742 | ) | (885 | ) | ||||||||||
|
Net (loss) income attributable to
common stockholders
|
$ | (5,367 | ) | $ | (7,060 | ) | $ | 2,490 | $ | (657 | ) | $ | 655 | |||||||
| (1) | Amortization of stock-based compensation is included in the line items above as follows: |
|
Three Months Ended |
||||||||||||||||||||
| Year Ended December 31, | March 31, | |||||||||||||||||||
| 2004 | 2005 | 2006 | 2006 | 2007 | ||||||||||||||||
| (Unaudited) | ||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||
|
Cost of revenues
|
$ | — | $ | — | $ | 12 | $ | — | $ | 9 | ||||||||||
|
Selling and marketing
|
— | — | 82 | 6 | 39 | |||||||||||||||
|
Research and development
|
— | — | 13 | — | 8 | |||||||||||||||
|
General and administrative
|
14 | 3 | 91 | 1 | 51 | |||||||||||||||
5
| • | on an actual basis without any adjustments to reflect subsequent or anticipated events; |
| • | on a pro forma basis reflecting (i) the conversion of all outstanding shares of our Series A, Series B, Series C, Series C-1, Series D and Series E preferred stock into an aggregate of 17,257,362 shares of our common stock effective immediately prior to the completion of this offering, for a total of 22,385,274 shares of common stock, which amount includes 347,635 shares subject to put rights and (ii) the reclassification of our preferred stock warrant liabilities from current liabilities to additional paid in capital effective upon the completion of this offering; and |
| • | on a pro forma as adjusted basis reflecting the conversion and reclassification described above and the receipt by us of the net proceeds from the sale of 5,000,000 shares of common stock in this offering at an assumed initial public offering price of $15.00 per share, the mid-point of the range on the front cover of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. |
| As of March 31, 2007 | ||||||||||||
|
Pro Forma |
||||||||||||
| Actual | Pro Forma | as Adjusted | ||||||||||
| (Unaudited) | ||||||||||||
| (In thousands) | ||||||||||||
|
Consolidated Balance Sheet
Data:
|
||||||||||||
|
Cash, cash equivalents and
short-term investments
|
$ | 18,181 | $ | 18,181 | $ | 84,931 | ||||||
|
Total current assets
|
34,520 | 34,520 | 101,270 | |||||||||
|
Total assets
|
45,479 | 45,479 | 112,229 | |||||||||
|
Total current liabilities
|
34,897 | 33,902 | 33,902 | |||||||||
|
Capital lease obligations,
long-term
|
1,896 | 1,896 | 1,896 | |||||||||
|
Common stock subject to put
|
4,392 | 4,392 | 4,392 | |||||||||
|
Redeemable preferred stock
|
102,580 | — | — | |||||||||
|
Stockholders’ equity (deficit)
|
(98,683 | ) | 4,892 | 71,642 | ||||||||
|
Three Months Ended |
||||||||||||||||||||
| Year Ended December 31, | March 31, | |||||||||||||||||||
| 2004 | 2005 | 2006 | 2006 | 2007 | ||||||||||||||||
| (Unaudited) | ||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||
|
Consolidated Statement of Cash
Flows Data:
|
||||||||||||||||||||
|
Net cash provided by operating
activities
|
$ | 1,907 | $ | 4,253 | $ | 10,905 | $ | 2,824 | $ | 3,156 | ||||||||||
|
Depreciation and amortization
|
2,745 | 5,123 | 4,259 | 1,059 | 1,154 | |||||||||||||||
|
Capital expenditures
|
1,208 | 1,071 | 2,314 | 292 | 494 | |||||||||||||||
6